Faeth Therapeutics Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 8

Faeth Therapeutics General Information

Description

Operator of a data-driven, evidence-based healthcare company intended to use a deep mechanistic understanding of cancer metabolism to help in the treatment of cancer. The company is focused on matching specific diets with tumor genotypes and treatment regimens that would limit the supply of energy and building blocks that tumors require in order to grow, thus helping the patients in their cancer treatments.

Contact Information

Website
www.faeththerapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • 237 Kearny Street
  • Suite 9245
  • San Francisco, CA 94108
  • United States

Faeth Therapeutics Timeline

202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Faeth Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 19-Jan-2022 $20M 000.00 Completed Startup
3. Early Stage VC 01-Jul-2021 000.00 Completed Startup
2. Seed Round 30-Nov-2020 $13.3M $13.3M 000.00 Completed Startup
1. Debt - PPP 30-Apr-2020 $101K Completed Startup
To view Faeth Therapeutics’s complete valuation and funding history, request access »

Faeth Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-3 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed-2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed-1 2,909,231 $0.000100 8% $0.52 $0.52 1x $0.52 11.73%
To view Faeth Therapeutics’s complete cap table history, request access »

Faeth Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Anand Parikh JD Co-Founder & Chief Executive Officer
Oliver Maddocks Ph.D Co-Founder & Head of Research
Siddhartha Mukherjee Ph.D Co-Founder
To view Faeth Therapeutics’s complete executive team members history, request access »

Faeth Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Faeth Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AgFunder Venture Capital Minority 000 0000 000000 0
Digitalis Ventures Venture Capital Minority 000 0000 000000 0
S2G Ventures Venture Capital Minority 000 0000 000000 0
Unshackled Ventures Venture Capital Minority 000 0000 000000 0
Cantos Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial